Novo Nordisk A/S (NYSE:NVO)

52.27
Delayed Data
As of Aug 23
 -0.43 / -0.82%
Today’s Change
41.23
Today|||52-Week Range
52.84
+13.46%
Year-to-Date

Stock Price Forecast

The 26 analysts offering 12-month price forecasts for Novo Nordisk A/S have a median target of 54.51, with a high estimate of 66.96 and a low estimate of 33.17. The median estimate represents a +4.29% increase from the last price of 52.27.

Analyst Recommendations

The current consensus among 27 polled investment analysts is to Buy stock in Novo Nordisk A/S. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.57
Sales
$4.5B
Reporting Date
Nov 01

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -6.52%
 
 
 
 
 
 
Growthannually 0.92%
 
 
 
 
 
 

Sales

Growthquarterly 0.29%
 
 
 
 
 
 
Growthannually 5.04%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.